Advertisement
Screener

Century Therapeutics, Inc. (IPSC) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Century Therapeutics, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Century Therapeutics, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $103.88M went out.
  • Fiscal year ended 2025-12-31: from investing, $107.50M came in.
  • Fiscal year ended 2025-12-31: from financing, $173.00K came in.
  • Fiscal year ended 2025-12-31: change in cash, $3.80M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backNew shares soldNot split outChange in cash
2025-12-31-$103.88M$107.50M$173.00K$3.80M
2024-12-31-$110.14M$47.48M$141.00K$74.42M*$11.91M
2023-12-31-$88.35M$61.13M-$10.24M$516.00K-$36.94M
2022-12-31$14.05M-$13.13M$345.00K$26.81M*$28.08M
2021-12-31-$89.00M-$298.34M$213.00K$417.56M*$30.43M
2020-12-31-$41.27M-$22.76M$47.69M*-$16.34M

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew shares soldNot split outChange in cash
2026-06-30-$19.83M*$17.77M*$347.00K*
2026-03-31-$25.26M-$112.61M$202.00K$126.42M*-$11.25M
2025-12-31-$16.08M*$22.36M*$53.00K*
2025-09-30-$25.58M*$24.67M*$0.00*
2025-06-30-$27.59M*$32.54M*$0.00*
2025-03-31-$34.62M$27.93M$120.00K-$6.57M
2024-12-31-$24.22M*$30.61M*-$602.00K*
2024-09-30-$28.33M*$39.20M*$273.00K*
2024-06-30-$27.33M*-$33.86M*$104.00K*$56.59M*
2024-03-31-$30.25M$11.54M$366.00K$17.83M*-$512.00K
2023-12-31-$26.23M*$18.60M*$0.00*-$356.00K*
2023-09-30-$13.65M*$4.22M*$0.00*$300.00K*
2023-06-30-$19.25M*$6.97M*$124.00K*-$10.24M*
2023-03-31-$29.22M$31.34M$448.00K$2.57M
2022-12-31-$22.91M*-$4.27M*$95.00K*
2022-09-30-$24.24M*$22.66M*$137.00K*
2022-06-30-$25.56M*$12.52M*$48.00K*
2022-03-31$86.75M-$44.04M$65.00K$26.81M*$69.59M
2021-12-31-$24.35M*-$20.60M*$83.00K*
2021-09-30-$23.98M*-$147.05M*$9.00K*
2021-06-30-$18.49M*-$11.65M*$74.00K*$224.57M*
2021-03-31-$22.18M-$119.03M$47.00K$193.44M*$52.27M
2020-12-31-$13.22M*-$20.78M*$38.10M*
2020-09-30-$9.22M*$476.00K*$9.60M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
SAB Biotherapeutics, Inc. (SABS)United States$0.306B-25.49
X4 Pharmaceuticals, Inc (XFOR)United States$0.297B-4.99
Inhibikase Therapeutics, Inc. (IKT)United States$0.296B-4.44
Liminatus Pharma, Inc. (LIMN)United States$0.282B
FATE THERAPEUTICS INC (FATE)United States$0.280B-2.51
Lexeo Therapeutics, Inc. (LXEO)United States$0.278B-4.19
PALISADE BIO, INC. (PALI)United States$0.275B-11.41
Invivyd, Inc. (IVVD)United States$0.270B-2.42
Ocugen, Inc. (OCGN)United States$0.343B-6.34
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05